Dutch company develops pill for lung cancer

The Netherlands is a pill for lung cancer Monday at the market.

The drug of the pharmaceutical company AstraZeneca is capable of some form of lung cancer, which affects thousands of Dutch, to suppress.

For patients, the pill, they swallow at home, a real boost, because they should not go to the hospital for chemotherapy.

"It is important that cancer patients immediately after diagnosis of this mutation to be tested," said Egbert Smit pulmonologist. Fifteen percent of all lung cancer patients Nederlandese that form would suffer. "These patients have a favorable prognosis and benefit from treatment other than chemotherapy."